New Study Looking at Substance Use for LBQ Women Overtime
Researchers at La Trobe University are now seeking participants for a new study about alcohol, tobacco and vaping among lesbian, bisexual and queer women (cisgender and transgender).
QSOX – Queer Women’s Substance Use Over Time is ARCSHS’ new longitudinal study of lesbian, bisexual, and queer women’s alcohol, tobacco, and vape use in Victoria and New South Wales. QSOX will explore what shapes substance use and help-seeking among LBQ women, with a view to informing service delivery in the future.
What does it involve?
This exciting project will involve being interviewed 3 times across 18 months to follow how things might change in that time. Participants will also have the option to share their reflections on substance use through a photography project. Participants will receive 3x $50 gift vouchers to thank them for their time. Participation is entirely voluntary and confidential.
Should I take part in the study?
You can be part of this study if you:
- Are aged 18 years or older
- Are a woman (either transgender or cisgender, or a nonbinary person who identifies with the category of woman)
- Identify as lesbian, bisexual, queer (or use another term to denote same or multi-gender attraction)
- Live in either Victoria or New South Wales
- Have smoked tobacco, vaped, or used e-cigarettes within the previous month; and/or
- Have consumed alcohol within the previous month
Sharing your knowledge and perspectives may help to make services more effective and sustainable, improving outcomes for LGBTIQ+ communities.
How to apply:
If you would like to participate, please express interest here: https://redcap.link/qye82sk2
For more information about this project, visit https://www.latrobe.edu.au/arcshs/work/qsox-queer-womens-substance-use-over-time or contact Dr Ruby Grant at email@example.com.
This study has been approved by the La Trobe University Human Research Ethics Committee (REF: 23018), the Thorne Harbour Health Community Research Endorsement Panel (CREP/THH/23-002), and the ACON Research Ethics Review Committee (Ref: 202306).